NSETrading Window24 Jun 2026 · 24 Jun 2026, 04:23 pm
Trading Window
Medicamen Biotech Limited · MEDICAMEQ
✦ AI Summary
Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The trading window will be closed for all Directors/Designated Persons/Connected Persons from July 01, 2026, and will remain closed till 48 hours after the declaration of Un-audited Financial Results for the quarter ended on June 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Medicamen Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
MEDICAMEQ_24062026162325_Trading_window_closure-Intimation.pdf
View document text
Date: 24.06.2026
BSE Limited National Stock Exchange of India Limited
25th Floor Exchange Plaza, C-1,
Phiroze Jeejebhoy Towers Block - G Bandra Kurla
Dalal Street, Mumbai 400 001 Complex Bandra (East)
Mumbai – 400 051
BSE Code-531146 NSE Code: MEDICAMEQ
Sub. : Intimation of Closure of Trading Window
Dear Sir,
In terms of the provisions of the Code of Conduct to Regulate, Monitor and Report trading by Designated
Persons and their immediate relative (“the Code”), the "Trading Window" for dealing in the securities of
the Company will be closed for all Directors / Designated Persons /Connected Persons under the Code
from July 01, 2026 and the same will remain closed till 48 hours after the declaration of Un-audited
Financial Results (Standalone & Consolidated) for the quarter ended on June 30, 2026, to the public.
Accordingly, all Directors / Designated Persons / Connected Persons under the Code have been advised
not to trade in the securities of the Company during the aforesaid period of closure of Trading Window.
The date of meeting of the Board of Directors of the Company inter alia, to approve the Un-audited
Financial Results (Standalone & Consolidated) of the Company for the aforesaid period will be intimated
separately in due course of time.
We request you to take the same on record.
Thanking You.
Yours Faithfully
For Medicamen Biotech Limited
Parul Choudhary
Company Secretary
ACS-44157